Buy Flunitrazolam 0.25mg Pellets
Buy Flunitrazolam 0.25mg Pellets $6.00 $18,043.00Price range: $6.00 through $18,043.00
Back to products
Buy Purple Mandala Mix
Buy Purple Mandala Mix $219.00 $15,746.00Price range: $219.00 through $15,746.00

Buy MaXTC 5-MAPB/4-FMA/5-MeO-MiPT

$6,995.00 $27,995.00Price range: $6,995.00 through $27,995.00

MaXTC is a research blend of 5-MAPB, 4-FMA, and 5-MeO-MiPT for studying stimulant and psychedelic neuropharmacology.

Shipping & Currency
CA CAD β†’ Canada
US USD β†’ USA
EU EUR β†’ Europe
Global 1-5 days β€’ Worldwide eligible
Switch: Left currency icon
Discreet shipping β€’ Support@chemwizards.ca
SKU: N/A Categories: , Tag:
Description

MaXTC Blend: 5-MAPB / 4-FMA / 5-MeO-MiPT Product Description

Introduction

MaXTC is a custom research chemical blend combining three psychoactive substances for the purpose of studying a broad range of stimulant and psychedelic effects. The blend includes 5-MAPB, 4-FMA, and 5-MeO-MiPTβ€”each with distinct pharmacological profiles impacting serotonin, dopamine, and norepinephrine neurotransmission, alongside psychedelic tryptamine activity.

Composition and Ingredients

5-MAPB (5-Methyl-3-(1,3-benzodioxol-5-yl)-2-aminopropane)

  • Empathogen and entactogen with effects similar to MDMA

  • Primarily serotonergic releasing agent with dopamine and norepinephrine release

  • Used in research for studying mood and social behaviour enhancement

4-FMA (4-Fluoromethamphetamine)

  • Stimulant closely related to methamphetamine

  • Promotes dopamine and serotonin release with increased potency and duration

  • Utilized in studies on stimulant abuse potential, neurotoxicology, and therapeutic options

5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine)

  • Psychedelic tryptamine inducing serotonin 5-HT2A receptor agonism

  • Produces hallucinogenic effects; used to research psychedelic and dissociative properties

  • Studied for entheogenic, therapeutic, and toxicological effects

Pharmacology and Mechanism of Action

  • The combined blend offers multimodal neurological effects including stimulation, empathy, and psychedelia

  • 5-MAPB and 4-FMA act mainly through monoamine transporter-mediated neurotransmitter release

  • 5-MeO-MiPT acts as a potent 5-HT2A receptor agonist producing hallucinogenic effects

Research Applications

  • Behavioral pharmacology studies on social, stimulant, and psychedelic interactions

  • Model for investigating neurotransmitter dynamics and receptor profiling

  • Toxicological and metabolic studies related to novel psychoactive substances

Safety and Handling Guidelines

  • Use protective equipment: gloves, lab coat, eye protection

  • Handle in appropriate chemical fume hoods or ventilated areas

  • Avoid direct contact and inhalation; follow local hazardous waste protocols

Regulatory Status

  • For laboratory research only, not approved for human use

  • Compliance with jurisdictional chemical control regulations required

Frequently Asked Questions (FAQs)

  1. What is MaXTC?
    A research blend of 5-MAPB, 4-FMA, and 5-MeO-MiPT.

  2. What types of effects does it produce?
    Combined stimulant, empathogenic, and psychedelic effects.

  3. How do the components act pharmacologically?
    5-MAPB and 4-FMA release monoamines; 5-MeO-MiPT activates 5-HT2A receptors.

  4. Are these substances safe for human use?
    No, research chemicals for lab use only; unknown safety profiles.

  5. How should the blend be handled?
    Use PPE and ventilated spaces; store safely and follow regulations.

Conclusion

MaXTC, combining 5-MAPB, 4-FMA, and 5-MeO-MiPT, is a versatile research chemical blend for studying complex interactions between stimulants and psychedelics. Its diverse pharmacology necessitates expert handling and rigorous safety protocols.

Additional information
Quantity

10 pellets

,

20 pellets

,

30 pellets

,

40 pellets

,

50 pellets

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Buy MaXTC 5-MAPB/4-FMA/5-MeO-MiPT”

Your email address will not be published. Required fields are marked *